Concepedia

Rebecca Noel

RN

Statistics

Publications

14

Citations

944

H-Index

11

Active since

2004

Affiliations

Eli Lilly (United States)(Current)

Clinical Research Institute

AstraZeneca (United States)

Johnson & Johnson (United States)

Janssen (United States)

Rebecca Noel is an author at Eli Lilly (United States) specializing in risk assessment, medicine, and regulatory benefit-risk assessment.

Publications per year

2004–2018

14

Publications

14

Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 Diabetes

Rebecca Noel, Daniel Braun, Ruth E. Patterson et al. · Diabetes Care · 2009 · 437 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

A cohort study of acute pancreatitis in relation to exenatide use

David D. Dore, Gary Bloomgren, Madé Wenten et al. · Diabetes Obesity and Metabolism · 2011 · 145 citations

Medicine, Internal Medicine, Pharmacology +10

Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study

Madé Wenten, J. A. Gaebler, Mohamed Hussein et al. · Diabetic Medicine · 2012 · 75 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Recommendations for benefit–risk assessment methodologies and visual representations

Diana Hughes, Ed Waddingham, Shahrul Mt‐Isa et al. · Pharmacoepidemiology and Drug Safety · 2016 · 70 citations · Full text

Pharmacy, Visualization, Decision Analysis +16

A Multiattribute Model for Evaluating the Benefit-Risk Profiles of Treatment Alternatives

James C. Felli, Rebecca Noel, Patrizia Cavazzoni · Medical Decision Making · 2008 · 59 citations

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17

1–5 of 14